NYSE: BMY

Bristol Myers Squibb Co. (BMY)

Bristol Myers Squibb Co. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker BMY. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BMY
Exchange
NYSE
SEC CIK
14272
Official filings
SEC EDGAR

Research BMY

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Bristol Myers Squibb Co.'s stock ticker?

Bristol Myers Squibb Co. trades under the ticker symbol BMY on NYSE. Its SEC Central Index Key (CIK) is 14272.

Where can I read Bristol Myers Squibb Co.'s SEC filings?

The BMY SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Bristol Myers Squibb Co. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BMY's financial statements?

The BMY Financials page shows Bristol Myers Squibb Co.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BMY compare with its peers and the market?

The BMY Peer Comparison page lines Bristol Myers Squibb Co. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500 and Nasdaq.

For information only — not investment advice.